secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicine Man Technologies, Inc. (—)
CIK:        0001622879
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001104659-24-043164
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Schwazze Q4 net loss $33.9M; FY23 revenue $172.4M, adjusted EBITDA $53.4M
-------------------------------------------------------------------------

- FY2023 revenue $172.4M, income from ops $3.3M; adjusted EBITDA $53.4M (31% of revenue), operating cash flow $12.2M.
- Q4 revenue $43.3M (+8% YoY) but net loss $33.9M due to $13.1M non-cash inventory adjustments (obsolescence, NRV, fair value).
- Retail footprint expanded 50% to 63 dispensaries via acquisitions of Everest Apothecary, Standing Akimbo, and Smokey’s.
- Total debt $156.8M at Dec 31, 2023 vs $127.8M a year earlier; cash $19.2M down from $38.9M.
- Interim CEO cites competitive pressure in Colorado and New Mexico; wholesale pricing stabilizing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/0001104659-24-043164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/tm2411011d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-043164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer